| Product NDC: | 0004-0800 |
| Proprietary Name: | Tamiflu |
| Non Proprietary Name: | oseltamivir phosphate |
| Active Ingredient(s): | 75 mg/1 & nbsp; oseltamivir phosphate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0004-0800 |
| Labeler Name: | Genentech, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021087 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19991027 |
| Package NDC: | 0004-0800-85 |
| Package Description: | 1 BLISTER PACK in 1 CARTON (0004-0800-85) > 10 CAPSULE in 1 BLISTER PACK |
| NDC Code | 0004-0800-85 |
| Proprietary Name | Tamiflu |
| Package Description | 1 BLISTER PACK in 1 CARTON (0004-0800-85) > 10 CAPSULE in 1 BLISTER PACK |
| Product NDC | 0004-0800 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | oseltamivir phosphate |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 19991027 |
| Marketing Category Name | NDA |
| Labeler Name | Genentech, Inc. |
| Substance Name | OSELTAMIVIR PHOSPHATE |
| Strength Number | 75 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Neuraminidase Inhibitor [EPC],Neuraminidase Inhibitors [MoA] |